HIGHLIGHTS
- who: Chris Cook and colleagues from the Division of Diabetes, Endocrinology and Gastroenterology, School of Medicine, University of Manchester have published the Article: The hypothalamic RFamide, QRFP, increases feeding and locomotor activity: The role of Gpr103 and orexin receptors, in the Journal: PLOS ONE of October/17,/2022
- what: The authors show that central administration of pyroglutamylated arginine-phenylamine-amide peptide (QRFP/26RFa) increases both food intake and locomotor activity without any significant effect on energy expenditure thermogenesis or reward. The authors compare the action of centrally administered QRFP with the behavioural effects of orexin . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.